Takeda wins Indonesia plasma license, plans up to $30 million pilot

The first-of-its-kind ASEAN initiative includes a two-year plasma donation center pilot and a study for a manufacturing facility as Indonesia seeks to expand access to plasma-derived therapies.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.